Clinical Trial Update: Viokase 16, Viokase16 Plus Nexium and Nexium Alone [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Viokase 16, Viokase16 Plus Nexium, and Nexium alone in chronic pancreatitis; the study was terminated and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• Nexium (esomeprazole)
• Viokase 16 (pancrelipase)
• Viokase16 Plus Nexium (pancrelipase + esomeprazole)

Snippet

Sponsor: University of Florida | Conditions: Chronic Pancreatitis | Phase 1 | Status: TERMINATED | Results posted: 2013-02-21